Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder
Open Access
- 3 May 2005
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 92 (10), 1906-1914
- https://doi.org/10.1038/sj.bjc.6602593
Abstract
Recepteur d'Origine Nantais (RON) is a distinct receptor tyrosine kinase in the c-met proto-oncogene family. We examined the mutational and expression patterns of RON in eight human uroepithelial cell lines. Biological effects of RON overexpression on cancer cells were investigated in vitro, and the prognostic significance of RON and/or c-met protein (MET) expression was analysed in a bladder cancer cohort (n=183). There was no evidence of mutation in the kinase domain of RON. Overexpression of RON using an inducible Tet-off system induced increased cell proliferation, motility, and antiapoptosis. Immunohistochemical analysis showed that RON was overexpressed in 60 cases (32.8%) of primary tumours, with 14 (23.3%) showing a high level of expression. Recepteur d'Origine Nantais expression was positively associated with histological grading, larger size, nonpapillary contour, and tumour stage (all PP=0.005) or metastasis-free survival (P=0.01) in 35 cases (19.1%). Recepteur d'Origine Nantais-associated signalling may play an important role in the progression of human bladder cancer. Evaluation of RON and MET expression status may identify a subset of bladder-cancer patients who require more intensive treatment.Keywords
This publication has 30 references indexed in Scilit:
- Signaling Through PI3K/Akt Mediates Stretch and PDGF-BB-Dependent DNA Synthesis in Bladder Smooth Muscle CellsJournal of Urology, 2003
- Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potentialOncogene, 2003
- Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivoOncogene, 2002
- The immortalized UROtsa cell line as a potential cell culture model of human urothelium.Environmental Health Perspectives, 2001
- Cross-talk between the proto-oncogenes Met and RonOncogene, 2000
- Overexpression of the RON gene in human breast carcinomaOncogene, 1998
- Co-expression and regulation ofMet andRon proto-oncogenes in human hepatocellular carcinoma tissues and cell linesHepatology, 1997
- Neu Differentiation Factor/Neuregulin Isoforms Activate Distinct Receptor CombinationsPublished by Elsevier BV ,1996
- The Relationship Among Multiple Recurrences, Progression and Prognosis of Patients with Stages TA and T1 Transitional Cell Cancer of the Bladder Followed for at least 20 yearsJournal of Urology, 1995
- Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor functionCell, 1990